BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
shalby limited stock

SHALBY LIMITED Share Price

244.65 -1.68 (-0.68%)
Dec 11 2024 03:29 PM Healthcare NSE: SHALBY

SHALBY LIMITED Share Price Update

As of the latest trading session, SHALBY LIMITED share price is currently at 244.65, which is down by -1.68 from its previous closing. Today, the stock has fluctuated between 243.11 and 248.70. Over the past year, SHALBY LIMITED has achieved a return of -22.59 %. In the last month alone, the return has been 12.54 %. Read More...

SHALBY LIMITED Performance

Day Range

Low243.11 High248.70
244.47

52 Week Range

Low 204.05 High 339.50
244.47

SHALBY LIMITED Share Price

714

540797

SHALBY

img img img img
No Data Available

Open Price

245.00

Prev. Close

246.33

Volume (Shares)

164751.00

Total traded value

402.76

Upper Circuit

295.59

Lower Circuit

197.06

Note: The current prices & values are delayed, Login to your account for live updates.

SHALBY LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 2627.84
PE Ratio (TTM) 27.79
Book Value / Share 101.67
Beta 1.23
ROE 10.22%
EPS (TTM) 8.80
Dividend Yield 0.49%
Net Profit Qtr (Cr) 17.34

SHALBY LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 212.27
Operating Expense 189.29
Net Profit 17.34
Net Profit Margin (%) 8.16
Earnings Per Share (EPS) 1.61
EBITDA 40.76
Effective Tax Rate (%) 38.71
Particulars JUN 2024 (Values in Cr)
Revenue 232.72
Operating Expense 194.58
Net Profit 30.47
Net Profit Margin (%) 13.09
Earnings Per Share (EPS) 2.84
EBITDA 58.05
Effective Tax Rate (%) 33.52
Particulars MAR 2024 (Values in Cr)
Revenue 206.32
Operating Expense 178.18
Net Profit 22.56
Net Profit Margin (%) 10.93
Earnings Per Share (EPS) 2.10
EBITDA 42.63
Effective Tax Rate (%) 30.62
Particulars DEC 2023 (Values in Cr)
Revenue 195.15
Operating Expense 161.88
Net Profit 24.72
Net Profit Margin (%) 12.66
Earnings Per Share (EPS) 2.30
EBITDA 48.41
Effective Tax Rate (%) 35.75
Particulars SEP 2023 (Values in Cr)
Revenue 217.09
Operating Expense 175.51
Net Profit 30.39
Net Profit Margin (%) 13.99
Earnings Per Share (EPS) 2.83
EBITDA 57.48
Effective Tax Rate (%) 35.77
Particulars MAR 2024 (Values in Cr)
Revenue 829.68
Operating Expense 691.93
Net Profit 103.85
Net Profit Margin (%) 12.51
Earnings Per Share (EPS) 9.67
EBITDA 198.27
Effective Tax Rate (%) 34.40
Particulars MAR 2023 (Values in Cr)
Revenue 708.02
Operating Expense 606.03
Net Profit 80.81
Net Profit Margin (%) 11.41
Earnings Per Share (EPS) 7.52
EBITDA 161.51
Effective Tax Rate (%) 33.41
Particulars MAR 2022 (Values in Cr)
Revenue 646.80
Operating Expense 555.43
Net Profit 69.81
Net Profit Margin (%) 10.79
Earnings Per Share (EPS) 6.46
EBITDA 138.21
Effective Tax Rate (%) 30.13
Particulars MAR 2021 (Values in Cr)
Revenue 418.67
Operating Expense 372.78
Net Profit 42.88
Net Profit Margin (%) 10.24
Earnings Per Share (EPS) 3.97
EBITDA 95.74
Effective Tax Rate (%) 22.72
Particulars MAR 2020 (Values in Cr)
Revenue 483.89
Operating Expense 444.60
Net Profit 27.97
Net Profit Margin (%) 5.78
Earnings Per Share (EPS) 2.59
EBITDA 99.25
Effective Tax Rate (%) 50.95
Particulars MAR 2024 (Values in Cr)
Book Value / Share 93.13
ROE % 8.66
ROCE % 11.59
Total Debt to Total Equity 0.29
EBITDA Margin 21.21
Particulars MAR 2023 (Values in Cr)
Book Value / Share 86.45
ROE % 7.50
ROCE % 10.33
Total Debt to Total Equity 0.19
EBITDA Margin 19.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 81.13
ROE % 6.31
ROCE % 8.85
Total Debt to Total Equity 0.12
EBITDA Margin 18.53
Particulars MAR 2021 (Values in Cr)
Book Value / Share 77.28
ROE % 5.19
ROCE % 6.70
Total Debt to Total Equity 0.07
EBITDA Margin 22.37
Particulars MAR 2020 (Values in Cr)
Book Value / Share 74.00
ROE % 3.49
ROCE % 7.36
Total Debt to Total Equity 0.08
EBITDA Margin 20.57
Particulars MAR 2024 (Values in Cr)
Book Value / Share 98.89
ROE % 10.22
ROCE % 14.70
Total Debt to Total Equity 0.08
EBITDA Margin 24.07
Particulars MAR 2023 (Values in Cr)
Book Value / Share 90.42
ROE % 8.61
ROCE % 12.67
Total Debt to Total Equity 0.04
EBITDA Margin 23.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 83.95
ROE % 7.95
ROCE % 11.07
Total Debt to Total Equity 0.05
EBITDA Margin 21.62
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.66
ROE % 5.16
ROCE % 6.63
Total Debt to Total Equity 0.06
EBITDA Margin 23.09
Particulars MAR 2020 (Values in Cr)
Book Value / Share 75.34
ROE % 3.48
ROCE % 7.27
Total Debt to Total Equity 0.08
EBITDA Margin 20.73
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 27.22
Total Assets 1607.53
Total Liabilities 1607.53
Total Equity 1007.78
Share Outstanding 107412505
Price to Book Ratio 2.42
Return on Assets (%) 5.23
Return on Capital (%) 6.36
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.28
Total Assets 1281.36
Total Liabilities 1281.36
Total Equity 927.61
Share Outstanding 107309770
Price to Book Ratio 1.49
Return on Assets (%) 5.28
Return on Capital (%) 6.33
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 110.56
Total Assets 1193.53
Total Liabilities 1193.53
Total Equity 876.18
Share Outstanding 108009770
Price to Book Ratio 1.39
Return on Assets (%) 4.53
Return on Capital (%) 5.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 83.57
Total Assets 996.62
Total Liabilities 996.62
Total Equity 834.67
Share Outstanding 108009770
Price to Book Ratio 1.28
Return on Assets (%) 4.25
Return on Capital (%) 4.82
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 28.73
Total Assets 966.63
Total Liabilities 966.63
Total Equity 799.20
Share Outstanding 108009770
Price to Book Ratio 0.61
Return on Assets (%) 2.85
Return on Capital (%) 3.25
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 9.22
Total Assets 1373.98
Total Liabilities 1373.98
Total Equity 1062.17
Share Outstanding 107412505
Price to Book Ratio 2.42
Return on Assets (%) 7.55
Return on Capital (%) 8.83
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.32
Total Assets 1165.65
Total Liabilities 1165.65
Total Equity 970.32
Share Outstanding 107309770
Price to Book Ratio 1.49
Return on Assets (%) 6.93
Return on Capital (%) 8.11
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 104.39
Total Assets 1087.38
Total Liabilities 1087.38
Total Equity 906.72
Share Outstanding 108009770
Price to Book Ratio 1.39
Return on Assets (%) 6.41
Return on Capital (%) 7.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 82.96
Total Assets 1012.25
Total Liabilities 1012.25
Total Equity 849.64
Share Outstanding 108009770
Price to Book Ratio 1.28
Return on Assets (%) 4.23
Return on Capital (%) 4.8
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 28.70
Total Assets 981.35
Total Liabilities 981.35
Total Equity 813.79
Share Outstanding 108009770
Price to Book Ratio 0.61
Return on Assets (%) 2.85
Return on Capital (%) 3.24
Particulars MAR 2024 (Values in Cr)
Net Income 128.19
Cash from Operations 39.66
Cash from Investing 38.07
Cash from Financing -150.69
Net change in Cash -93.02
Free Cash Flow 86.76
Particulars MAR 2023 (Values in Cr)
Net Income 102.04
Cash from Operations 96.18
Cash from Investing -61.07
Cash from Financing -50.00
Net change in Cash -43.30
Free Cash Flow 114.66
Particulars MAR 2022 (Values in Cr)
Net Income 79.14
Cash from Operations 41.90
Cash from Investing -60.30
Cash from Financing 90.45
Net change in Cash 49.07
Free Cash Flow 117.29
Particulars MAR 2021 (Values in Cr)
Net Income 55.05
Cash from Operations 88.24
Cash from Investing -51.26
Cash from Financing -29.85
Net change in Cash -1.97
Free Cash Flow 109.10
Particulars MAR 2020 (Values in Cr)
Net Income 56.72
Cash from Operations 75.53
Cash from Investing -30.66
Cash from Financing -21.49
Net change in Cash 3.20
Free Cash Flow 95.30
Particulars MAR 2024 (Values in Cr)
Net Income 158.31
Cash from Operations 159.53
Cash from Investing -206.00
Cash from Financing 72.13
Net change in Cash 5.90
Free Cash Flow 190.80
Particulars MAR 2023 (Values in Cr)
Net Income 121.35
Cash from Operations 191.59
Cash from Investing -172.40
Cash from Financing -38.21
Net change in Cash -46.08
Free Cash Flow 195.04
Particulars MAR 2022 (Values in Cr)
Net Income 99.92
Cash from Operations 123.73
Cash from Investing -40.31
Cash from Financing -17.24
Net change in Cash 43.36
Free Cash Flow 158.40
Particulars MAR 2021 (Values in Cr)
Net Income 55.49
Cash from Operations 86.48
Cash from Investing -51.83
Cash from Financing -27.82
Net change in Cash -2.41
Free Cash Flow 107.28
Particulars MAR 2020 (Values in Cr)
Net Income 57.02
Cash from Operations 77.10
Cash from Investing -32.27
Cash from Financing -21.49
Net change in Cash 3.31
Free Cash Flow 96.87
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7256.20 88.19 13.92 104333.02 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 62.73 0.00 3.94 117.57 44.00 / 107.94
SHREE PACETRONIX LTD. 118.35 19.06 3.17 42.60 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.49 0.00 5.23 56.75 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7256.20 92.91 12.73 104333.02 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 56.18 0.00 -30.09 41.97 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5366.00 29.10 6.02 5870.40 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 244.80
  • 26 Days 232.00
  • 10 Days 238.30
  • 50 Days 241.30
  • 12 Days 235.90
  • 100 Days 255.70
  • 20 Days 231.60
  • 200 Days 295.70
246.94
PIVOT
First Resistance 248.78
Second Resistance 251.23
Third Resistance 253.07
First Support 244.49
Second Support 242.65
Third Support 240.20
RSI 60.35
MACD 3.89
Commodity Channel Index (CCI) 128.52
ADX 30.77
Williams % R -9.97

Over 1 Month

down

12.54

Over 3 Months

down

-12.64

Over 6 Months

down

-12.10

Over 1 Year

down

-22.59

Over 3 Years

down

20.45

Over 5 Years

down

20.81

SHALBY LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SHALBY LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
20.29
Promoter Holdings
74.24
FII
5.37
DII
0.09
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Shah Family Trust Throuh Dr. Vikram Shah, Trustee Shareholding of Promoter and Promoter Group 3.7517132E7 34.73
Zodiac Mediquip Limited Shareholding of Promoter and Promoter Group 3.1545448E7 29.21
Vikram Indrajit Shah Shareholding of Promoter and Promoter Group 7980493.0 7.39
Darshini Vikram Shah Shareholding of Promoter and Promoter Group 3012525.0 2.79
Shanay Vikram Shah Shareholding of Promoter and Promoter Group 137525.0 0.13
Kairav Kirit Shah Shareholding of Promoter and Promoter Group 250.0 0.0

SHALBY LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-08-08 1.2 Final 2023-08-09 Equity shares 2022-09-19 1.0 Final 2022-09-21 Equity shares 2021-09-17 1.0 Final 2021-09-21 Equity shares 2020-09-04 0.5 Final 2020-09-08 Equity shares 2019-08-16 0.5 Final 2019-08-20 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Shalby share result highlights

Shalby’s recent financial results highlight stable growth in its healthcare operations, reflecting positive revenue and profitability. The Shalby share price reacted favourably to these results, with revenue showing an increase due to higher patient admissions and improved hospital occupancy rates. The company’s profit margins also improved, driven by cost optimisation efforts and enhanced service offerings. EBITDA growth has been strong, signalling the company’s continued focus on operational efficiency. Investors remain optimistic about Shalby’s future prospects, expecting these strong financial results to further boost the Shalby share price as the company continues to expand its presence in the healthcare sector.
 

Shalby share annual reports

Shalby’s annual reports provide a detailed view of the company’s financial health and strategic direction over the past year. The company recorded steady revenue growth, which positively impacted the Shalby share price. The balance sheet highlights the company’s strong cash flow and efficient cost management, which have contributed to a stable financial position. The annual reports also detail future plans for expanding hospital networks and enhancing patient care services, which are expected to strengthen the company’s market presence and positively affect the Shalby share price in the coming years.
 

Shalby share dividend

Shalby has maintained a consistent dividend policy, providing regular returns to shareholders. The Shalby share price responded positively to recent dividend announcements, reflecting investor confidence in the company’s financial stability. The dividend payout in the last financial year aligned with market expectations, ensuring that shareholders are rewarded while the company retains capital for future growth. Shalby’s balanced dividend approach continues to attract investor interest, supporting both shareholder value and the company’s long-term growth strategy, which positively impacts the Shalby share price.

About SHALBY LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SHALBY LIMITED

Learn More About Stocks

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Shalby Ltd?

Answer Field

The share price of Shalby Ltd for NSE is ₹ 244.65 and for BSE is ₹ 244.2.

What is the Market Cap of Shalby Ltd?

Answer Field

The market cap of Shalby Ltd for NSE is ₹ 26,27.84 Cr. and for BSE is ₹ 26,23.01 Cr. as of now.

What is the 52 Week High and Low of Shalby Ltd?

Answer Field

The 52 Week High and Low of Shalby Ltd for NSE is ₹ 339.50 and ₹ 204.05 and for BSE is ₹ 333.85 and ₹ 204.50.

How to Buy Shalby Ltd share?

Answer Field

You can trade in Shalby Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Shalby Ltd?

Answer Field

The 1 year returns on the stock has been -22.59%.

What is the Current Share Price of Shalby Ltd?

Answer Field

Shalby Ltd share price is for NSE ₹ 244.65 & for BSE ₹ 244.2 as on Dec 11 2024 03:29 PM.

What is the Market Cap of Shalby Ltd Share?

Answer Field

The market cap of Shalby Ltd for NSE ₹ 26,27.84 & for BSE ₹ 26,23.01 as on Dec 11 2024 03:29 PM.

What is the P/E Ratio of Shalby Ltd Share?

Answer Field

As on Dec 11 2024 03:29 PM the price-to-earnings (PE) ratio for Shalby Ltd share is 27.79.

What is the PB ratio of Shalby Ltd Share?

Answer Field

As on Dec 11 2024 03:29 PM, the price-to-book (PB) ratio for Shalby Ltd share is 101.67.

How to Buy Shalby Ltd Share?

Answer Field

You can trade in Shalby Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shalby Ltd Share on Bajaj Broking App?

Answer Field

To buy Shalby Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shalby Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Popular FAQs
 

Who is the CEO of Shalby?

The CEO of Shalby is responsible for leading the company’s strategic vision and overseeing its healthcare operations. Under their leadership, Shalby has continued to grow and expand its presence in the healthcare industry. The CEO’s focus on enhancing service quality and operational efficiency has contributed to the company’s positive financial performance, which has had a direct influence on the Shalby share price. Investors watch the CEO’s decisions closely to assess the company’s future prospects.
 

When was Shalby established?

Shalby was established several decades ago, entering the healthcare sector with a focus on providing quality medical services. Since its inception, the company has grown steadily, contributing to the rise in the Shalby share price. Over the years, Shalby has expanded its hospital network and diversified its service offerings, becoming a recognised name in the healthcare industry. The company’s establishment laid the foundation for its current success and continued market presence.
 

What factors influence the Shalby share price?

Several factors influence the Shalby share price, including the company’s financial performance, patient admissions, and operational efficiency. Internal factors such as revenue growth, profitability, and service expansion also play a critical role. External factors like industry trends, healthcare demand, and government policies further impact the share price. Investors carefully monitor these variables to assess potential movements in the Shalby share price and make informed decisions based on market and company performance.
 

Is Shalby debt free?

Shalby is not entirely debt-free but maintains a manageable level of debt that supports its growth and expansion plans. The company’s financial reports reflect that its debt levels are well-controlled and do not pose significant risks to its operations. This prudent debt management strategy positively impacts investor confidence and the Shalby share price, as the company continues to maintain financial stability while pursuing growth opportunities in the healthcare sector.
 

How has the Shalby share price performed over the past year?

The Shalby share price has experienced moderate fluctuations over the past year, influenced by the company’s financial performance and broader market conditions. While the share price saw periods of growth driven by strong earnings and hospital expansions, it also faced some volatility due to external factors. Overall, the Shalby share price has remained stable, reflecting the company’s solid position in the healthcare industry. Investors continue to monitor the company’s performance closely for future growth potential.

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader